| Medicare Palmetto | Billing and Coding: Home Health Plans of Care: Monitoring Glucose Control in the Medicare Home Health Population with Type II Diabetes Mellitus (56674) | 2025-04-09 |
| Medicare Palmetto | Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (58277) | 2025-04-09 |
| Aetna | Epidural Injection Technologies | 2025-04-08 |
| Aetna | Sirolimus Protein-Bound Particles for Injectable Suspension Albumin-Bound (Fyarro) | 2025-04-08 |
| Aetna | Lifileucel (Amtagvi) | 2025-04-08 |
| Medical Mutual | Rhinoplasty, Septoplasty, and Non-Ablative | 2025-04-08 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Treatments for Lymphedema | 2025-04-07 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Medication Assisted Treatment for Opioid Use Disorder: Methadone | 2025-04-07 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Intraepidermal Nerve Fiber Density Testing | 2025-04-07 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus | 2025-04-07 |